Scinai Immunotherapeutics Ltd. issued a notice to shareholders regarding a clarification in the Proxy Statement for the Annual General Meeting scheduled for June 16, 2026. The filing clarifies the expiration term of the Services Agreement for Chairman Mark Germain in relation to Proposal No. 6.
